Transforming Growth Factor-β, Bioenergetics, and Mitochondria in Renal Disease

Gabriella Casalena, Ilse Daehn, Erwin Bottinger

Research output: Contribution to journalArticlepeer-review

92 Scopus citations

Abstract

The transforming growth factor-β (TGF-β) family comprises more than 30 family members that are structurally related secreted dimeric cytokines, including TGF-β, activins, and bone morphogenetic proteins/growth and differentiation factors. TGF-β are pluripotent regulators of cell proliferation, differentiation, apoptosis, migration, and adhesion of many different cell types. TGF-β pathways are highly evolutionarily conserved and control embryogenesis, tissue repair, and tissue homeostasis in invertebrates and vertebrates. Aberrations in TGF-β activity and signaling underlie a broad spectrum of developmental disorders and major pathologies in human beings, including cancer, fibrosis, and autoimmune diseases. Recent observations have indicated an emerging role for TGF-β in the regulation of mitochondrial bioenergetics and oxidative stress responses characteristic of chronic degenerative diseases and aging. Conversely, energy and metabolic sensory pathways cross-regulate mediators of TGF-β signaling. Here, we review TGF-β and regulation of bioenergetic and mitochondrial functions, including energy and oxidant metabolism and apoptotic cell death, as well as their emerging relevance in renal biology and disease.

Original languageEnglish
Pages (from-to)295-303
Number of pages9
JournalSeminars in Nephrology
Volume32
Issue number3
DOIs
StatePublished - May 2012

Keywords

  • Apoptosis
  • Cytokine
  • Fibrosis
  • Mitochondria
  • Signal transduction

Fingerprint

Dive into the research topics of 'Transforming Growth Factor-β, Bioenergetics, and Mitochondria in Renal Disease'. Together they form a unique fingerprint.

Cite this